JPMorgan Chase & Co. boosted its position in shares of Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report) by 68.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 30,403 shares of the company’s stock after purchasing an additional 12,383 shares during the quarter. JPMorgan Chase & Co. owned 0.07% of Quipt Home Medical worth $89,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of the company. Hsbc Holdings PLC grew its holdings in Quipt Home Medical by 10.4% during the second quarter. Hsbc Holdings PLC now owns 52,522 shares of the company’s stock valued at $165,000 after purchasing an additional 4,969 shares during the period. State Street Corp boosted its holdings in shares of Quipt Home Medical by 1.0% in the third quarter. State Street Corp now owns 621,388 shares of the company’s stock valued at $1,814,000 after buying an additional 6,317 shares during the period. Jane Street Group LLC boosted its holdings in shares of Quipt Home Medical by 28.5% in the third quarter. Jane Street Group LLC now owns 41,926 shares of the company’s stock valued at $122,000 after buying an additional 9,290 shares during the period. ProShare Advisors LLC acquired a new position in shares of Quipt Home Medical in the second quarter valued at approximately $35,000. Finally, SG Americas Securities LLC acquired a new position in shares of Quipt Home Medical in the third quarter valued at approximately $44,000. Institutional investors and hedge funds own 42.85% of the company’s stock.
Quipt Home Medical Stock Up 1.9 %
Quipt Home Medical stock opened at $3.23 on Monday. The company has a quick ratio of 0.86, a current ratio of 1.20 and a debt-to-equity ratio of 0.73. The stock has a market capitalization of $139.18 million, a PE ratio of -21.53 and a beta of 0.56. Quipt Home Medical Corp. has a twelve month low of $2.30 and a twelve month high of $4.99. The company has a 50 day moving average of $2.82 and a 200-day moving average of $2.89.
Insiders Place Their Bets
In related news, VP Patrick Dennis Gamble purchased 17,000 shares of the company’s stock in a transaction that occurred on Thursday, December 26th. The stock was acquired at an average price of $2.45 per share, with a total value of $41,650.00. Following the completion of the purchase, the vice president now directly owns 40,057 shares in the company, valued at $98,139.65. This trade represents a 73.73 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 4.20% of the company’s stock.
Quipt Home Medical Company Profile
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.
Featured Stories
- Five stocks we like better than Quipt Home Medical
- Conference Calls and Individual Investors
- 3 Stocks to Gain From Trump’s Return-to-Office Mandate
- 3 Dividend Kings To Consider
- Crane Stock Soars, But the Best Could Be Yet to Come: Here’s Why
- Dividend Capture Strategy: What You Need to Know
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
Want to see what other hedge funds are holding QIPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quipt Home Medical Corp. (NASDAQ:QIPT – Free Report).
Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.